[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Pages 92791-92792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30590]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant an Exclusive License; Adaptive Phage 
Therapeutics, Inc.

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant Adaptive Phage Therapeutics, Inc. a revocable, nonassignable, 
exclusive license to practice worldwide the Government owned inventions 
described in U.S. Provisional Patent Application 62/353,517, filed 22 
June 2016 and entitled ``Bacteriophage compositions and methods of 
selection of components against specific bacteria'' as well as any 
issued patent, divisional or continuation from that and related foreign 
filings in the field of antibiotics and drug-resistant bacteria 
control.

DATES: Anyone wishing to object to the grant of this license has 
fifteen (15) days from the date of this notice to file written 
objections along with supporting evidence, if any, not later than 
January 4, 2017.

[[Page 92792]]


ADDRESSES: Written objections are to be filed with Attn: Naval Medical 
Research Center, Code 1URO/OPBD, 503 Robert Grant Avenue, Silver 
Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. T.A. Ponzio, Director, 
Partnerships & Business Development, Naval Medical Research Center, 503 
Robert Grant Ave., Silver Spring, MD 20910-7500; 
[email protected]; telephone: 240-762-0673.

    Authority: 35 U.S.C. 207, 37 CFR part 404.


    Dated: December 14, 2016.
A.M. Nichols,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
[FR Doc. 2016-30590 Filed 12-19-16; 8:45 am]
 BILLING CODE 3810-FF-P